SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001615219-20-000044
Filing Date
2020-04-29
Accepted
2020-04-28 19:37:57
Documents
6
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A salarius-defa14aexerciseyo.htm DEFA14A 26249
2 image_01.jpg GRAPHIC 2384
3 salarius-ntcxfinal_pagex11.jpg GRAPHIC 1443682
4 salarius-ntcxfinal_pagex21.jpg GRAPHIC 237471
5 salarius-ntcxfinal_pagex31.jpg GRAPHIC 79297
6 salarius-ntcxfinal_pagex41.jpg GRAPHIC 31091
  Complete submission text file 0001615219-20-000044.txt   2495867
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36812 | Film No.: 20826842
SIC: 2834 Pharmaceutical Preparations